subject area of
- Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination Journal Articles
- Advancing Novel Molecular Imaging Agents from Preclinical Studies to First-in-Humans Phase I Clinical Trials in Academia—A Roadmap for Overcoming Perceived Barriers Journal Articles
- Andexanet alfa for the treatment of hemorrhage Journal Articles
- BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies Journal Articles
- Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital Journal Articles
- CCI-779 Wyeth. Journal Articles
- Clinical trial design in metastatic breast cancer: a commentary. Journal Articles
- Drug evaluation: E-5564. Journal Articles
- Financial Concerns Prompt Sponsoring Pharmaceutical Company to Halt International Phase I Studies Journal Articles
- Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors Journal Articles
- Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials Journal Articles
- Human Gene Marker/Therapy Clincal Protocols (Complete Updated Listings) Journal Articles
- Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future? Journal Articles
- Idarucizumab Journal Articles
- Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials Journal Articles
- Improved up‐and‐down designs for phase I trials Journal Articles
- Improving the Quality of Abstract Reporting for Phase I Cancer Trials Journal Articles
- International phase 1 study protocol to develop a health state classification system for a preference-based measure for women with breast cancer: the BREAST-Q Utility module Journal Articles
- International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gender-affirming treatments (the GENDER-Q) Journal Articles
- Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval Journal Articles
- Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Journal Articles
- Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival Journal Articles
- Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? Journal Articles
- Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab Journal Articles
- Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells Journal Articles
- Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology Journal Articles
- Remote ischemic conditioning in necrotizing enterocolitis: study protocol of a multi-center phase II feasibility randomized controlled trial Journal Articles
- Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors Journal Articles
- The arotinoids: early clinical experience and discussion of future development. Journal Articles
- The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries Journal Articles
- Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials Journal Articles
- Use and Misuse of Waterfall Plots Journal Articles